Novel functional PI 3‐kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines
- 1 June 2000
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 14 (9) , 1179-1187
- https://doi.org/10.1096/fasebj.14.9.1179
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Italiana per la Ricerca sul Cancro (E0841)
This publication has 33 references indexed in Scilit:
- Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: A new intracellular signalling system?Published by Elsevier ,2003
- Signalling through phosphoinositide 3-kinases: the lipids take centre stageCurrent Opinion in Cell Biology, 1999
- Activation of phospholipase Cgamma by PI 3-kinase-induced PH domain-mediated membrane targetingThe EMBO Journal, 1998
- Phosphoinositide 3-kinases: A conserved family of signal transducersPublished by Elsevier ,1997
- High Affinity Binding of Inositol Phosphates and Phosphoinositides to the Pleckstrin Homology Domain of RAC/Protein Kinase B and Their Influence on Kinase ActivityPublished by Elsevier ,1997
- Phosphoinositide 3-kinase and the regulation of cell growthBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activationBiochemical Journal, 1996
- Pleckstrin domain homologyNature, 1993
- A putative modular domain present in diverse signaling proteinsCell, 1993
- Inositol trisphosphate and calcium signallingNature, 1993